Warby Parker price to book ratio WRBY
Market value divided by the book value of the company's net assets, since 2021.
- Today, Oct 23, 2026
- 8.2×
- 5-year median
- 6.6×
- Against its 5-year history
- 71st
- percentile: 0 is its lowest day, 100 its highest
- 5-year range
- 3.9× to 22.6×
- Peer median
- 4.2×
Warby Parker's price to book ratio is 8.2× as of Oct 23, 2026.
That is above its 5-year median of 6.6×, higher than on 71% of days in the last 5 years.
Over that time it ranged from 3.9× in Nov 2023 to 22.6× in Nov 2021.
The median for 10 medical instruments and supplies stocks of a similar size is 4.2×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 8.2× | 6.8× | 9.6× |
| 2025 | 8.0× | 5.1× | 9.9× |
| 2024 | 8.7× | 4.6× | 9.0× |
| 2023 | 5.4× | 3.9× | 6.8× |
| 2022 | 5.5× | 4.6× | 15.4× |
| 2021 | 18.1× | 17.8× | 22.6× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Warby Parker's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| WRBYWarby Parker | 8.2× |
| ATRCAtriCure | 5.8× |
| NVSTEnvista | 1.2× |
| ICUIICU Medical | 1.9× |
| BMIBadger Meter | 6.4× |
| UFPTUFP Technologies | 5.0× |
| VNTVontier | 3.9× |
| INSPInspire Medical Systems | 2.5× |
| LMATLemaitre Vascular | 4.6× |
| HAEHaemonetics | 6.4× |
| MMSIMerit Medical Systems | 3.3× |
| Peer median | 4.2× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Warby Parker
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.